[Federal Register Volume 62, Number 219 (Thursday, November 13, 1997)] [Notices] [Page 60910] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-29844] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Cancer Institute Special Emphasis Panel (SEP) meeting: Name of SEP: Cancer Drug Discovery: Diversity Generation and Smart Assays. Date: December 14-16, 1997. Time: December 14-7:00 p.m. to Recess, December 15-8:00 a.m. to Recess, December 16-8:00 a.m. to Adjournment. Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209. Contact Person: Ray Bramhall, Ph.D., Scientific Review Administrator, National Cancer Institute, NIH, Executive Plaza North, Room 643, 6130 Executive Boulevard, MSC 7407, Bethesda, MD 20892-7407, Telephone: 301/496-3428. Purpose/Agenda: To review, discuss and evaluate grant applications. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Program Numbers: 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control) Dated: November 6, 1997. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 97-29844 Filed 11-12-97; 8:45 am] BILLING CODE 4140-01-M